Selecting weight loss surgery based on HDL genotype - Are we there yet? At the brink of "personalized surgery"

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages 1664-1667

  Rother, Kristina I ^a   Brown, Rebecca J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; EDITORIAL; GASTRIC BANDING; GASTROPLASTY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

BARIATRIC SURGERY; CHOLESTEROL, HDL; HUMANS; INDIVIDUALIZED MEDICINE; OBESITY;

EID: 79956291627     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2011-0686     Document Type: Editorial

References (20)

1. Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjostrom L, Carlsson LM, Bouchard C 2011 Association of GWAS-based candidate genes with HDL-cholesterol levels before and after bariatric surgery in the Swedish Obese Subjects Study. J Clin Endocrinol Metab 96:E953-E957
2. Torgerson JS, Sjostrom L 2001 The Swedish Obese Subjects (SOS) study-rationale and results. Int J Obes Relat Metab Disord 25(Suppl 1):S2-S4 (Pubitemid 32565145)
3. Gagne DJ, Dovec E, Urbandt JE 5 November 2010 Laparoscopic revision of vertical banded gastroplasty to roux-en-Y gastric bypass: outcomes of 105 patients. Surg Obes Relat Dis doi:10.1016/j.soard.2010.10.014
4. Nandagopal R, Brown RJ, Rother KI 2010 Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents. Diabetes Technol Ther 12:671-677
5. Franco JV, Ruiz PA, Palermo M, Gagner M 1 April 2011 A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg doi: 10.1007/s11695-011-0390-5
6. Rodriguez L, Reyes E, Fagalde P, Oltra MS, Saba J, Aylwin CG, Prieto C, Ramos A, Galvao M, Gersin KS, Sorli C 2009 Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 11:725-732
7. Sjöström L 2008 Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 32(Suppl 7):S93-S97
8. Grover SA, Kaouache M, Joseph L, Barter P, Davignon J 2009 Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Arch Intern Med 169:1775-1780
9. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs Jr DR, Bangdiwala S, Tyroler HA 1989 High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8-15
10. Brown BG, Zhao XQ 2008 Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk. Am J Cardiol 101:58B-62B
11. Bogardus C 2009 Missing heritability and GWAS utility. Obesity (Silver Spring) 17:209-210
12. McCarthy MI 2010 Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339-2350
13. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA 2009 Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41:56-65
14. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, et al. 2010 Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707-713
15. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR 2008 Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 3:e3081
16. Voora D, Shah SH, Reed CR, Zhai J, Crosslin DR, Messer C, Salisbury BA, Ginsburg GS 2008 Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ Cardiovasc Genet 1:100-106
17. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM 2007 Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752 (Pubitemid 47295641)
18. Kimura A 2009 Does a gene polymorphism predisposing to an intermediate phenotype predict the risk of disease? A lesson from CETP, high-density lipoprotein-cholesterol and coronary heart disease. Circ J 73:1016-1017
19. Gutierrez C, Schiff R 2011 HER2: biology, detection, and clinical implications. Arch Pathol Lab Med 135:55-62
20. Teer JK, Mullikin JC 2010 Exome sequencing: the sweet spot before whole genomes. Hum Mol Genet 19:R145-R151